Page 566 - Read Online

Maurina et al. Mini-invasive Surg 2021;5:53 https://dx.doi.org/10.20517/2574-1225.2021.88 Page 13 of 13

J Am Coll Cardiol 2021;78:297-313. DOI PubMed
39. Sedaghat A, Vij V, Al-Kassou B, et al. Device-related thrombus after left atrial appendage closure: data on thrombus characteristics,
treatment strategies, and clinical outcomes from the EUROC-DRT-registry. Circ Cardiovasc Interv 2021;14:e010195. DOI PubMed
40. Sedaghat A, Nickenig G, Schrickel JW, et al; EWOLUTION study group. Incidence, predictors and outcomes of device-related
thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry.
Catheter Cardiovasc Interv 2021;97:E1019-24. DOI PubMed
41. Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device
in patients with atrial fibrillation: a PROTECT AF (Percutaneous closure of the left atrial appendage versus warfarin therapy for
prevention of stroke in patients with atrial fibrillation) substudy. J Am Coll Cardiol 2012;59:923-9. DOI PubMed
42. Lempereur M, Aminian A, Freixa X, et al. Device-associated thrombus formation after left atrial appendage occlusion: a systematic
review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet. Catheter Cardiovasc Interv 2017;90:E111-
21. DOI PubMed
43. Godino C, Melillo F, Bellini B, et al. Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients
with non-valvular atrial fibrillation and high bleeding risk. EuroIntervention 2020;15:1548-54. DOI PubMed
44. Osmancik P, Herman D, Neuzil P, et al; PRAGUE-17 Trial Investigators. Left atrial appendage closure versus direct oral
anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol 2020;75:3122-35. DOI PubMed
45. Duthoit G, Silvain J, Marijon E, et al. Reduced rivaroxaban dose versus dual antiplatelet therapy after left atrial appendage closure:
ADRIFT a randomized pilot study. Circ Cardiovasc Interv 2020;13:e008481. DOI PubMed